PH27400A - New therapeutically active compound and method of use thereof - Google Patents

New therapeutically active compound and method of use thereof

Info

Publication number
PH27400A
PH27400A PH39732A PH39732A PH27400A PH 27400 A PH27400 A PH 27400A PH 39732 A PH39732 A PH 39732A PH 39732 A PH39732 A PH 39732A PH 27400 A PH27400 A PH 27400A
Authority
PH
Philippines
Prior art keywords
active compound
therapeutically active
new therapeutically
new
compound
Prior art date
Application number
PH39732A
Other languages
English (en)
Inventor
Arne Elof Brandstrom
Sunnel Elizabeth Sunden
Per Lennart Lindberg
Original Assignee
Arne Elof Brandstrom
Sunnel Elizabeth Sunden
Per Lennart Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arne Elof Brandstrom, Sunnel Elizabeth Sunden, Per Lennart Lindberg filed Critical Arne Elof Brandstrom
Publication of PH27400A publication Critical patent/PH27400A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH39732A 1988-12-22 1989-12-19 New therapeutically active compound and method of use thereof PH27400A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19888804629A SE8804629D0 (sv) 1988-12-22 1988-12-22 New therapeutically active compounds

Publications (1)

Publication Number Publication Date
PH27400A true PH27400A (en) 1993-06-21

Family

ID=20374310

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39732A PH27400A (en) 1988-12-22 1989-12-19 New therapeutically active compound and method of use thereof

Country Status (32)

Country Link
US (2) US5008278A (de)
EP (1) EP0449940B1 (de)
JP (1) JP2793906B2 (de)
KR (1) KR910700249A (de)
CN (1) CN1028231C (de)
AR (1) AR248136A1 (de)
AT (1) ATE127799T1 (de)
AU (1) AU634741B2 (de)
BG (1) BG60102B2 (de)
CA (1) CA2005986C (de)
DD (2) DD296078A5 (de)
DE (1) DE68924273T2 (de)
DK (1) DK170800B1 (de)
EG (1) EG19303A (de)
FI (2) FI913035A0 (de)
GR (1) GR1002252B (de)
HR (1) HRP920831A2 (de)
HU (2) HU205927B (de)
IE (1) IE894048L (de)
IL (1) IL92798A0 (de)
LT (2) LT3914B (de)
LV (1) LV10187B (de)
NZ (1) NZ231872A (de)
PH (1) PH27400A (de)
PL (1) PL161150B1 (de)
PT (1) PT92648B (de)
RO (1) RO110494B1 (de)
RU (2) RU2073676C1 (de)
SE (1) SE8804629D0 (de)
WO (1) WO1990006925A1 (de)
YU (1) YU46806B (de)
ZA (2) ZA899795B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
TNSN95063A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux benzimidazoles substitues
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
DE19758573C2 (de) * 1997-11-26 2001-03-01 Implex Hear Tech Ag Fixationselement für ein implantierbares Mikrofon
EP1004305B1 (de) * 1998-04-20 2011-09-28 Eisai R&D Management Co., Ltd. Stabilisierte zusammenstellungen die benzimidazole enthalten
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
RU2232159C2 (ru) * 1999-07-29 2004-07-10 Регентский Совет Университета Калифорнии Производные бензимидазола и фармацевтические композиции, содержащие пролекарство ингибитора протонного насоса
DE60036014T2 (de) 1999-10-20 2008-04-30 Eisai R&D Management Co., Ltd. Methode zur stabilisierung von benzimidazol-verbindungen
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US20050234103A1 (en) * 2002-03-26 2005-10-20 Reddy Manne S Crystalline forms of rabeprazole sodium
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
RU2325960C2 (ru) * 2005-09-22 2008-06-10 Белорусский Национальный Технический Университет Способ получения товарной продукции на литейно-прокатном комплексе металлургического мини-завода
AU2007278986B2 (en) 2006-07-25 2010-09-16 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (de) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428098A (en) 1890-05-20 Electric railway
US727150A (en) 1902-06-18 1903-05-05 Peter Paul Keller Adjustable hanger for incandescent lamps.
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (de) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3215503A1 (de) 1982-04-26 1983-11-03 Zängl GmbH, 8000 München Elektrisch beheiztes schneidgeraet
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL71664A (en) * 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS6261978A (ja) * 1985-09-12 1987-03-18 Otsuka Pharmaceut Co Ltd ５−フルオロ−１ｈ−ベンズイミダゾ−ル誘導体
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
JPH0676323B2 (ja) * 1987-08-28 1994-09-28 東京田辺製薬株式会社 抗潰瘍剤

Also Published As

Publication number Publication date
RO110494B1 (ro) 1996-01-30
KR910700249A (ko) 1991-03-14
US5039808A (en) 1991-08-13
DE68924273T2 (de) 1996-02-15
SE8804629D0 (sv) 1988-12-22
BG60102B2 (bg) 1993-10-29
CA2005986A1 (en) 1990-06-22
DE68924273D1 (de) 1995-10-19
DK122291D0 (da) 1991-06-21
WO1990006925A1 (en) 1990-06-28
IE894048L (en) 1990-06-22
EG19303A (en) 1994-11-30
EP0449940B1 (de) 1995-09-13
FI913035A7 (fi) 1991-06-20
LV10187A (lv) 1994-10-20
DK170800B1 (da) 1996-01-22
NZ231872A (en) 1992-03-26
HU205927B (en) 1992-07-28
CA2005986C (en) 1999-08-03
AU634741B2 (en) 1993-03-04
FI913035A0 (fi) 1991-06-20
LT3914B (en) 1996-04-25
CN1028231C (zh) 1995-04-19
PL161150B1 (en) 1993-05-31
HU205926B (en) 1992-07-28
YU46806B (sh) 1994-06-10
YU242689A (en) 1991-04-30
RU2073676C1 (ru) 1997-02-20
JPH04502461A (ja) 1992-05-07
RU2042673C1 (ru) 1995-08-27
ATE127799T1 (de) 1995-09-15
ZA899794B (en) 1990-08-29
HUT57202A (en) 1991-11-28
FI954768L (fi) 1995-10-06
PT92648B (pt) 1995-09-12
EP0449940A1 (de) 1991-10-09
DD296078A5 (de) 1991-11-21
GR890100838A (el) 1991-03-15
AR248136A1 (es) 1995-06-30
LV10187B (en) 1995-04-20
ZA899795B (en) 1990-08-29
PT92648A (pt) 1990-06-29
LT3980B (en) 1996-06-25
LTIP1721A (en) 1995-07-25
LTIP1726A (en) 1995-07-25
AU4817590A (en) 1990-07-10
HRP920831A2 (en) 1995-12-31
FI954768A7 (fi) 1995-10-06
HU901084D0 (en) 1991-09-30
DK122291A (da) 1991-06-24
FI954768A0 (fi) 1995-10-06
GR1002252B (en) 1996-04-23
IL92798A0 (en) 1990-09-17
DD296079A5 (de) 1991-11-21
JP2793906B2 (ja) 1998-09-03
US5008278A (en) 1991-04-16
CN1043713A (zh) 1990-07-11

Similar Documents

Publication Publication Date Title
PH27400A (en) New therapeutically active compound and method of use thereof
AU584469B2 (en) Lightweight nonwoven tissue and method of manufacture
GB2215267B (en) Disposable faceshield and method of manufacture thereof
EP0203768A3 (en) A therapeutic effervescent composition and a method of preparing the same
AU5947886A (en) Tablet package and method of use
PH23495A (en) Phenoxyalkylaminopyrimidine derivatives and the composition and method of use thereof
IL98618A0 (en) Improved ointment base and method of use
PH21588A (en) Pleuromutilin derivatives and method of use thereof
AU587182B2 (en) Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters
HU893412D0 (en) Inhibitors of interleucin-1
AU590640B2 (en) Dementia-improving and therapeutic agents
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
ZA897446B (en) Antimicrobial composition and method of use
AU576717B2 (en) N6 - bicycloadenosines and methods of use
ZA876845B (en) Pharmacologically active compounds and use
JPS6450846A (en) Arylbisperfluoroalkylcarbinol and manufacture of same
GB2220652B (en) Treatment of pastures
ZA874979B (en) Pharmacologically active compounds and use
PH22427A (en) Eburnamenine derivatives and method of use thereof
ZA846720B (en) Process for the preparation of a therapeutically active compound and a new therapeutical use of the same
AU4219789A (en) Treatment of superconducting materials
PL271176A1 (en) Method of obtaining active aluminium oxide
PL271175A1 (en) Method of obtaining active aluminium oxide
YU62088A (en) Rolling of roll-cotton
ZA852625B (en) Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters